Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/ncomms9483 http://scihub22266oqcxt.onion/10.1038/ncomms9483 C4598845!4598845!26404464     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Commun 2015 ; 6 (ä): ä Nephropedia Template TP {{tp|p=26404464|t=2015. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis |pdf=|usr=}}{{26404464}} gab.com Text CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis JO: Nat Commun http://www.kidney.de/pget.php?&tw=1&pmid=26404464 #FOAvip The complement system is important for the host defence against infection as well as for the development of inflammatory diseases. Here we show that C1q/TNF-related protein 6 (CTRP6; gene symbol C1qtnf6) expression is elevated in mouse rheumatoid arthritis (RA) models. C1qtnf6?/? mice are highly susceptible to induced arthritis due to enhanced complement activation, whereas C1qtnf6-transgenic mice are refractory. The Arthus reaction and the development of experimental autoimmune encephalomyelitis are also enhanced in C1qtnf6?/? mice and C1qtnf6?/? embryos are semi-lethal. We find that CTRP6 specifically suppresses the alternative pathway of the complement system by competing with factor B for C3(H2O) binding. Furthermore, treatment of arthritis-induced mice with intra-articular injection of recombinant human CTRP6 cures the arthritis. CTRP6 is expressed in human synoviocytes, and CTRP6 levels are increased in RA patients. These results indicate that CTRP6 is an endogenous complement regulator and could be used for the treatment of complement-mediated diseases. Twit Text FOAVip CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis ????Nat Commun http://www.kidney.de/pget.php?&tw=1&pmid=26404464 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26404464 #FOAvip English Wikipedia <ref>{{Cite pmid|26404464}}</ref> CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis #MMPMID26404464 Murayama MA; Kakuta S; Inoue A; Umeda N; Yonezawa T; Maruhashi T; Tateishi K; Ishigame H; Yabe R; Ikeda S; Seno A; Chi HH; Hashiguchi Y; Kurata R; Tada T; Kubo S; Sato N; Liu Y; Hattori M; Saijo S; Matsushita M; Fujita T; Sumida T; Iwakura Y Nat Commun 2015[]; 6 (ä): ä PMID26404464show ga The complement system is important for the host defence against infection as well as for the development of inflammatory diseases. Here we show that C1q/TNF-related protein 6 (CTRP6; gene symbol C1qtnf6) expression is elevated in mouse rheumatoid arthritis (RA) models. C1qtnf6?/? mice are highly susceptible to induced arthritis due to enhanced complement activation, whereas C1qtnf6-transgenic mice are refractory. The Arthus reaction and the development of experimental autoimmune encephalomyelitis are also enhanced in C1qtnf6?/? mice and C1qtnf6?/? embryos are semi-lethal. We find that CTRP6 specifically suppresses the alternative pathway of the complement system by competing with factor B for C3(H2O) binding. Furthermore, treatment of arthritis-induced mice with intra-articular injection of recombinant human CTRP6 cures the arthritis. CTRP6 is expressed in human synoviocytes, and CTRP6 levels are increased in RA patients. These results indicate that CTRP6 is an endogenous complement regulator and could be used for the treatment of complement-mediated diseases. äCTRP6 is an endogenous complement regulator that can effectively treat(epmc).pdf DeepDyve Pubget Overpricing